Catalogo dei prodotti della ricerca

MEZZAROMA, Ivano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.888
EU - Europa 3.120
AS - Asia 1.633
SA - Sud America 72
AF - Africa 47
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.767
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.808
IT - Italia 1.029
UA - Ucraina 746
SG - Singapore 706
IN - India 513
SE - Svezia 478
CN - Cina 299
FI - Finlandia 286
DE - Germania 189
IE - Irlanda 108
GB - Regno Unito 93
CA - Canada 68
AR - Argentina 57
BG - Bulgaria 43
MY - Malesia 37
ID - Indonesia 29
RU - Federazione Russa 26
BE - Belgio 25
TG - Togo 24
FR - Francia 23
NL - Olanda 20
TR - Turchia 15
RO - Romania 14
MX - Messico 9
BR - Brasile 7
SC - Seychelles 7
CL - Cile 6
EG - Egitto 6
AU - Australia 5
ES - Italia 5
HK - Hong Kong 5
IL - Israele 5
IR - Iran 5
LT - Lituania 5
PH - Filippine 5
ZA - Sudafrica 5
AT - Austria 4
PL - Polonia 4
AL - Albania 3
CH - Svizzera 3
GR - Grecia 3
KR - Corea 3
LV - Lettonia 3
BO - Bolivia 2
BZ - Belize 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BJ - Benin 1
EE - Estonia 1
EU - Europa 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TZ - Tanzania 1
Totale 13.767
Salva come PNG Salva come JPEG
Città #
Fairfield 1.050
Woodbridge 834
Chandler 785
Houston 540
Singapore 522
Ann Arbor 517
Ashburn 485
Seattle 414
Wilmington 395
Cambridge 359
Princeton 353
Jacksonville 309
Rome 308
Plano 244
Santa Clara 241
Dearborn 159
Beijing 150
Boston 121
San Paolo di Civitate 116
San Diego 112
Dublin 108
Lawrence 105
Millbury 81
Boardman 67
Andover 66
Federal 57
Milan 57
Helsinki 54
Norwalk 54
Fremont 50
Sofia 43
New York 40
Toronto 34
Bremen 30
Des Moines 29
Jakarta 29
Los Angeles 29
Falls Church 27
Brussels 25
Ottawa 25
Lomé 24
San Mateo 20
Dallas 19
Bühl 18
Falkenstein 17
Mannheim 17
Auburn Hills 14
Istanbul 13
Kunming 13
Nanjing 13
London 11
Redmond 11
Amsterdam 10
Hefei 10
Napoli 10
Perugia 10
Florence 9
Guangzhou 9
Palermo 8
Redwood City 8
Taurisano 8
Phoenix 7
Chengdu 6
Jinan 6
Moscow 6
Nanchang 6
Berlin 5
Bologna 5
Frankfurt am Main 5
Indiana 5
Induno Olona 5
Messina 5
Naples 5
Tel Aviv 5
Vernole 5
Washington 5
Albano Laziale 4
Castelnuovo Rangone 4
Fuzhou 4
Hong Kong 4
Hounslow 4
Laurel 4
Mascalucia 4
Mexico City 4
Pesaro 4
Philadelphia 4
Pomezia 4
San Jose 4
San Nicolás de los Garza 4
Simi Valley 4
Venafro 4
Wuhan 4
Athens 3
Baltimore 3
Barcelona 3
Barrie 3
Brandizzo 3
Buffalo 3
Castellammare di Stabia 3
Catania 3
Totale 9.465
Salva come PNG Salva come JPEG
Nome #
Linee guida per la diagnosi e terapia dell'Immunodeficienza Comune Variabile (ICV) 335
Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents 144
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study 121
TRANSMITTED DRUG RESISTANCE MUTATIONS AND TRENDS OF HIV-1 SUBTYPES IN TREATMENT-NAÏVE PATIENTS: A SINGLE CENTER EXPERIENCE 118
HIV-1 induces in vivo platelet activation by enhancing platelet NOX2 activity. 118
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 114
Antiphospholipid syndrome and anticoagulation quality: A clinical challenge 108
An oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1-infected women independently of protease inhibitors therapy: a pilot study 106
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 105
Ansia, depressione, eventi stressanti in soggetti affetti da malattia HIV in confronto con pazienti affetti da immunodeficienza primitiva. 102
A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients 100
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19). Relationship with mortality 100
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns 98
Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis 96
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) 94
Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles 91
Mutational resistance pattern of HIV type 1 in CD14+ monocytes, CD4+ T cells, and plasma from treated patients 91
A critical immunological and serological evaluation of patients with HTLV III/LAV related disorders. 88
Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage regimen: 72-week follow-up 84
Antiviral activity of fecal water samples from HIV-1 infected subjects treated with a specific probiotic formulation 84
ANALYSIS OF THE CYTOLYTIC ACTIVITY MEDIATED BY NATURAL-KILLER-CELLS FROM ACQUIRED-IMMUNODEFICIENCY-SYNDROME PATIENTS IN RESPONSE TO PHYTOHEMAGGLUTININ OR ANTI-CD16 MONOCLONAL-ANTIBODY 82
Reply to. "monitoring antivitamin K anticoagulants in antiphospholipid syndrome. a challenge in quality" 82
Decreased apoptosis of bone marrow progenitor cells in HIV-1-infected patients during highly active antiretroviral therapy 82
CD4 AS THE RECEPTOR FOR RETROVIRUSES OF THE HTLV FAMILY - IMMUNOPATHOGENETIC IMPLICATIONS 81
Recovery of haematopoietic abnormalities in HIV-1 infected patients treated with HAART 80
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 80
T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART 78
Immunological aspects and thymic hormone therapy of Herpetic Keratitis. 78
APOPTOSIS-RELATED MORTALITY IN-VITRO OF MONONUCLEAR-CELLS FROM PATIENTS WITH HIV-INFECTION CORRELATES WITH DISEASE SEVERITY AND PROGRESSION 78
Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients 78
IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection 77
ANTI-HCV ANTIBODIES IN GAMMA-GLOBULIN FOR INTRAVENOUS USE 76
MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients 76
Copy-years viremia and risk of virological failure in long-term-treated HIV patients 75
A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection 75
Immunodysregulation of HIV disease at bone marrow level 74
Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patients 74
HIV-1 INFECTION - EPIDEMIOLOGICAL FEATURES AND IMMUNOLOGICAL ALTERATIONS DURING THE NATURAL-HISTORY OF THE DISEASE 74
Leptin levels in HIV-positive patients treated with HAART 73
An emotionally inexpressive (type C) coping style influences HIV disease progression at six and twelve month follow-ups 73
DELAYED AND DEFECTIVE ANTI-HIV IGM RESPONSE IN INFANTS 73
Psychological problems in subjects with AIDS and related syndromes. 72
Autoantibodies to Estrogen Receptor α in Systemic Sclerosis (SSc) as Pathogenetic Determinants and Markers of Progression 72
Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication 72
Contact dermatitis in subjects infected with HIV type 1 71
Characterization of specific immune complexes in HIV-related disorders. 71
Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitors 70
Comparison of a rule-based algorithm with a phenotype-based algorithm for the interpretation of HIV genotypes in guiding salvage regimens in HIV-infected patients by a randomized clinical trial: The mutations and salvage study 70
Idiopathic CD4+ lymphocytopenia may be due to decreased bone marrow clonogenic capability 70
Brainstem CMV encephalitis in AIDS: Clinical case and MRI features 69
null 69
null 69
A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia 69
THYMOSTIMULIN TREATMENT IN AIDS-RELATED COMPLEX 68
Human infection with Cryptosporidium felis: Case report and literature review 68
UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE - AN UNSOLVED PROBLEM: REVISION OF LITERATURE AND CASE STUDIES 68
Real word outcomes associated with use of raltegravir in older people living with HIV: results from the 60 months follow-up of the RAL-age cohort 68
Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients 68
Functional bone marrow analysis in HIV-1+ patients pre- and post-HAART 67
Potential benefit of dolutegravir once daily: Efficacy and safety 67
Correlation between enzyme-linked immunosorbent assay and immunofluorescence assay with lytic antigens for detection of antibodies to human herpesvirus 8 67
CD4 as the receptor for retroviruses of the HTLV family:immunopathogenetic implications. 67
Immunological aspects of patients with HIV-1 disease following immunization with recombinant gp160 (VaxSyn). 67
Lithiasis of semicircular canals and parotid glands: unusual stones deposition in atazanavir-treated individuals. 66
DELAYED APPEARANCE OF HIV-INFECTION IN CHILDREN 66
SERUM EOSINOPHIL CATIONIC PROTEIN (ECP) IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION 65
Mechanisms of disease progression and CD4 depletion in HIV-1 infection. 65
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 65
Dolutegravir: clinical efficacy and role in HIV therapy. 65
PROVIRAL SEQUENCES DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN SERONEGATIVE SUBJECTS BY POLYMERASE CHAIN-REACTION 64
null 64
A case of acanthosis nigricans in a HIV-infected patient 64
Italian Society Of Allergy And Clinical Immunology Guidelines For The Diagnosis And Treatment Of Common Variable Immunodeficiency (Cvid) 63
Immunopathogenesis of AIDS 63
Problematiche psicologiche nei malati di AIDS e sindromi correlate. 63
Immunomodulatory Effects of Intravenous Immunoglobulins (IVIGs) in HIV-1 Disease: A Systematic Review 63
Backbone switch to abacavir/lamivudine fixed-dose combination: implications for antiretroviral therapy optimization 63
Switching to a bictegravir single tablet regimen in elderly people living with HIV-1. Data analysis from the BICTEL Cohort 63
Usefulness of calcaneal quantitative ultrasound stiffness for the evaluation of bone health in HIV-1-infected subjects: Comparison with dual X-ray absorptiometry 62
Bone marrow clonogenic capability, cytokine production, and thymic output in patients with common variable immunodeficiency 62
HIV-1 DIVERSITY AND ANTIRETROVIRAL RESISTANCE MUTATIONS AMONG TREATMENT NAÏVE PATIENTS FROM 2005-2017: A SINGLE CENTER EXPERIENCE 62
Glecaprevir/pibrentasvir ultra-short treatment to cure HCV infection: case report and literature review 62
PARVOVIRUS INFECTION IN CHILDREN WITH AIDS - HIGH PREVALENCE OF B19-SPECIFIC IMMUNOGLOBULIN-M AND IMMUNOGLOBULIN-G ANTIBODIES 61
Clinical management of patients with primary immunodeficiencies during the COVID-19 pandemic 61
Studio dei potenziali evocati multimodali in pazienti in differenti stadi dell'infezione da HIV-1. 60
IMPIEGHI CLINICI DELLE IMMUNOGLOBULINE PER VIA ENDOVENOSA (IVIgG) IN PAZIENTI AFFETTI DA MALATTIA DA HIV-1 60
LACK OF EVIDENCE FOR A SUPERANTIGEN IN LYMPHOCYTES FROM HIV-DISCORDANT MONOZYGOTIC TWINS 60
Acute cystitis by Ureaplasma urealyticum in a patients with Acquired Immunodeficiency Syndrome. 59
AIDS: Stato attuale e prospettive terapeutiche. 59
HEPATITIS-C VIRUS-ANTIBODIES IN GAMMA-GLOBULIN 59
V3 Net Charge: Additional Tool in HIV-1 Tropism Prediction. 59
null 59
Lymphocyte subsets and functional changes in HIV-1 infected patient during HAART. 58
Correlation between HIV-induced serologic findings and retinal lesions in patients with AIDS 58
MONITORING OF DRUG RESISTANCE MUTATIONS IN PROVIRAL DNA OF PATIENTS RESPONDING TO ANTIRETROVIRAL THERAPY 58
Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease 58
USE OF HEMATOPOIETIC GROWTH FACTORS (RECOMBINANT HUMAN ERYTHROPOIETIN AND GRANULOCYTE COLONY-STIMULATING FACTOR) IN HIV-1 INFECTIONS 58
PROLIFERATIVE AND CYTOTOXIC RESPONSES TO MANNOPROTEINS OF CANDIDA-ALBICANS BY PERIPHERAL-BLOOD LYMPHOCYTES OF HIV-INFECTED SUBJECTS 57
Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis 57
null 57
Totale 7.703
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.477
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.697 0 0 0 0 0 387 301 324 229 264 132 60
2020/20211.235 149 143 32 120 33 161 33 117 98 225 98 26
2021/20222.487 23 154 205 107 348 61 53 270 210 231 355 470
2022/20232.779 588 401 202 289 336 273 48 202 255 34 125 26
2023/20241.037 72 183 55 92 110 83 11 50 6 143 100 132
2024/20251.065 99 206 172 144 266 178 0 0 0 0 0 0
Totale 14.177